LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis You-Quan WangGuo HuangWen-Ting Xu Editorial 29 March 2021 Pages: 1 - 14
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting Yahya AlmodallalJennifer G. Le-RademacherAminah Jatoi Review 12 June 2021 Pages: 15 - 20
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies Naomi DempseyAmanda RosenthalNanette H. Bishopric Review 11 June 2021 Pages: 21 - 36
M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma Vidya AroleHiroaki NittaZaibo Li Preclinical study 25 May 2021 Pages: 37 - 42
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA Tilak K. SundaresanTaronish D. DubashDaniel A. Haber Preclinical study 08 June 2021 Pages: 43 - 52
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ Abdulbaqi Al-KawazIslam M. MiligyEmad A. Rakha Preclinical study Open access 12 June 2021 Pages: 53 - 63
Activity of trastuzumab emtansine (T-DM1) in 3D cell culture Jean Zheng BoyerGail D. Lewis PhillipsPenny Towne Preclinical study Open access 05 June 2021 Pages: 65 - 75
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES Young-Hyuck ImBulent KarabulutSung-Bae Kim Clinical trial 16 March 2021 Pages: 77 - 89
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer Pavani ChalasaniKiah FarrHannah Linden Clinical trial Open access 02 April 2021 Pages: 91 - 99
Comparison of mastectomy and breast reconstruction outcomes using low thermal dissection versus traditional electrocautery: a blinded randomized trial Mehran HabibiVishnu PrasathKristen P. Broderick Clinical trial 19 March 2021 Pages: 101 - 106
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI Yukiko TokudaMasahiro YanagawaNoriyuki Tomiyama Clinical trial 17 March 2021 Pages: 107 - 115
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial Norikazu MasudaHiroko BandoMasakazu Toi Clinical trial Open access 25 March 2021 Pages: 117 - 131
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS Eileen RakovitchSameer ParpiaTimothy J. Whelan Clinical trial 08 April 2021 Pages: 133 - 139
Prosigna test in breast cancer: real-life experience D HequetG HarrissartR Rouzier Clinical trial 15 April 2021 Pages: 141 - 147
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer Nicolò Matteo Luca BattistiMaria Sol AndresAlistair Ring Clinical trial 05 April 2021 Pages: 149 - 163
Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer Sung Gwe AhnSeon-Kyu KimCharles M. Perou Clinical trial Open access 26 March 2021 Pages: 165 - 178
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry Peter A. KaufmanSara A. HurvitzMohammad Jahanzeb Epidemiology 28 February 2021 Pages: 179 - 190
Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study Ingrid M. LizarragaAmanda R. KahlSonia L. Sugg Epidemiology 13 February 2021 Pages: 191 - 202
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors Kyae Hyung KimSeulggie ChoiSang Min Park Epidemiology 18 February 2021 Pages: 203 - 214
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies Samuel G. SmithIvana SestakJack Cuzick Epidemiology Open access 03 March 2021 Pages: 215 - 223
Characterization of estrogen receptor-low-positive breast cancer Fei FeiGene P. SiegalShi Wei Epidemiology 10 March 2021 Pages: 225 - 235
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing Pongtawat LertwilaiwittayaEkkapong RoothumnongManop Pithukpakorn Epidemiology Open access 01 March 2021 Pages: 237 - 248
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic Ko Un ParkMegan GregoryAlastair Thompson Epidemiology 02 March 2021 Pages: 249 - 258
Variations in breast cancer surgical treatment and timing: determinants and disparities Irene Dankwa-MullanJudy GeorgeYull E. Arriaga Epidemiology Open access 10 March 2021 Pages: 259 - 272
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study Angela ChetritSivan Ben-AvrahamSiegal Sadetzki Epidemiology 05 April 2021 Pages: 273 - 282
Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women Juhua LuoCandyce H. KroenkeJean Wactawski-Wende Epidemiology 07 March 2021 Pages: 283 - 293
Male and female breast cancer: the two faces of the same genetic susceptibility coin Susana Nunes SilvaBruno Costa GomesJosé Rueff Epidemiology Open access 03 May 2021 Pages: 295 - 305
Mammography use and breast cancer incidence among older U.S. women Sara D. TurbowMary C. WhiteSusan A. Sabatino Epidemiology 05 March 2021 Pages: 307 - 316
Barriers and engagement in breast cancer survivorship wellness activities Kristin L. SzuhanyMatteo MalgaroliNaomi M. Simon Brief Report 07 June 2021 Pages: 317 - 325
Reply to the letter on sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer Andrea P. Damin Letter to the Editor 08 June 2021 Pages: 327 - 328
